Max Reinhardt

2021

In 2021, Max Reinhardt earned a total compensation of $2M as President, Rest of World at Pacira Pharmaceuticals, a 15% decrease compared to previous year.

Compensation breakdown

Bonus$275,000
Non-Equity Incentive Plan$197,578
Option Awards$485,540
Salary$551,100
Stock Awards$426,720
Other$30,869
Total$1,966,808

Reinhardt received $551.1K in salary, accounting for 28% of the total pay in 2021.

Reinhardt also received $275K in bonus, $197.6K in non-equity incentive plan, $485.5K in option awards, $426.7K in stock awards and $30.9K in other compensation.

Rankings

In 2021, Max Reinhardt's compensation ranked 6,113th out of 12,406 executives tracked by ExecPay. In other words, Reinhardt earned more than 50.7% of executives.

ClassificationRankingPercentile
All
6,113
out of 12,406
51st
Division
Manufacturing
2,585
out of 5,494
53rd
Major group
Chemicals And Allied Products
1,127
out of 2,369
52nd
Industry group
Drugs
1,003
out of 2,090
52nd
Industry
Pharmaceutical Preparations
724
out of 1,537
53rd

Pay ratio

Max Reinhardt's Pay$1,966,808
Median Employee's Pay$199,797
Pay Ratio

10

to 1

In 2021, the annual total compensation of Max Reinhardt was $1,966,808.

The annual total compensation of the median employee at Pacira Pharmaceuticals was $199,797.

The ratio of Max Reinhardt's pay to the pay of median employee was therefore 10 to one.

Source: SEC filing on April 22, 2022.

Reinhardt's colleagues

We found four more compensation records of executives who worked with Max Reinhardt at Pacira Pharmaceuticals in 2021.

2021

David Stack

Pacira Pharmaceuticals

Chief Executive Officer

2021

Roy Winston

Pacira Pharmaceuticals

Chief Medical Officer

2021

Jonathan Slonin

Pacira Pharmaceuticals

Chief Clinical Officer

2021

Charles Reinhart

Pacira Pharmaceuticals

Chief Financial Officer

News

You may also like